Co-Investment, From the Side That Offers It
Co-investment is an allocation decision before it is an offer. Section 206 requires the conflict be disclosed for informed consent, and examiners found policies that went unfollowed.
Read this pieceInsights
Growth Equity, page 2
LeverVenture is an operator-led, mid-market growth equity firm in life sciences and healthcare, the bridge between venture capital and private equity. These pieces cover that passage: deal structures, market conditions, finance and the operating work that carries a company from proof to scale.
Field notes, diligence method, operating and capital
Written by the partner or operator who did the work
§ 01 / 02
The archive
Page 2 of 2, newest first.
Every piece filed under Growth Equity is listed in order across these pages, each with the line that says what it covers. The newest pieces are on the pages before this one.
The full index
Page 2 of 2, newest first.
Platform Company Build-and-Buy Strategy: Scaling Through M&A
Platform strategies rarely fail on deal pricing. They fail because integration capacity, not deal flow, is the real constraint on how many acquisitions a platform can absorb.
Read this pieceOperating Partner Evolution: Beyond Advisory to Value Creation
Operating partners shifted from advisory presence to accountable ownership. The real design question is how compensation and authority are structured, not who is hired.
Read this pieceMiddle Market Private Equity: The Overlooked Sweet Spot
The middle market is not buyout in miniature. Less intermediated sourcing, operational rather than financial leverage, and a wider exit set explain why.
Read this pieceThe Management Fee, and What It Actually Pays For
A management fee is an operating budget. Read it function by function, then against the step-downs and offsets that shrink it, under ILPA Principles 3.0 and the Advisers Act.
Read this pieceFund of Funds, and Why an Emerging Manager Meets One
A fund of funds is how major public pension emerging-manager programs reach first-time private equity managers. What it underwrites in a first fund, and what it asks for.
Read this pieceThe Hurdle Rate, Defined Against Market Convention
The hurdle rate centers on 8% in private equity, but the compounding basis, the start of the clock and the catch-up decide what it protects.
Read this pieceCross-Border Investment: Navigating Complexity for Returns
A company spanning borders faces five separate underwriting problems: screening, data residency, treaty structure, currency exposure, and enforcement risk.
Read this pieceCarve-Out Acquisitions: The Execution Playbook
A carve-out prices at a discount because separation is real work, not margin. Here is what a TSA, stranded costs, and untangled shared IP actually cost a buyer.
Read this pieceBuilding Value Beyond Capital: Our Force Multiplier Approach
LeverVenture's Force Multiplier Approach pairs capital with operational support across go-to-market, operations, talent, M&A and exit preparation.
Read this pieceGrowth Equity Firms in AI Healthcare: The Operator's Playbook for Raising Growth Capital in 2025
A founder-level guide to growth equity firms investing in AI healthcare — due diligence frameworks, valuation drivers, reimbursement risk, and exit pathways covered.
Read this piece§ 02 / 02
Research
The State of Growth Equity, 2026 edition.
The first edition of our read on the passage between venture capital and private equity: who is funding it, what it costs, and where the companies that stall in it actually stall.
01
Executive summary
Free, no form. The findings, the method and every chart that carries one — complete, not a teaser, and the same text that opens the full report.
02
The full report
Sixty-four pages, this first edition, released to a named reader. One form, one reply, and no list you did not ask to be on.
Contact
Have a question about something here, or want to discuss it? We would be glad to hear from you.